Full Text View
Tabular View
No Study Results Posted
Related Studies
A Pharmacokinetic Dose Proportionality Study of Canagliflozin in Healthy Volunteers
This study has been completed.
Study NCT01340677   Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

First Received on April 21, 2011.   Last Updated on August 16, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy
Interventions listed in this trial
Canagliflozin, 50 mg
Canagliflozin, 300 mg
Canagliflozin, 100 mg
Sponsors listed in this trial
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services